#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Squamous cell carcinoma of head and neck Autoimmune hepatitis Juvenile chronic myelomonocytic leukaemia Microvillous inclusion disease Usher's syndrome Colon cancer Palmar-plantar erythrodysaesthesia syndrome Neoplasm malignant Phaeochromocytoma Small intestine neuroendocrine tumour Univentricular heart Breast cancer Hypotransferrinaemia Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Phenylketonuria – Treatment Osteosarcoma metastatic Marfan’s syndrome – Trials in Disease Netherton’s syndrome – Trials in Disease Progressive multifocal leukoencephalopathy – Basic Information Hereditary angioedema Focal segmental glomerulosclerosis Pulmonary fibrosis – Basic Information Fabry’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lisinopril Dihydrate Terbinafine Cefuroxime Sucrose Clopidogrel Hydrogen Sulfate Op-1250 Tofersen Concizumab Capsaicin Metamizole Atomoxetine Cevostamab Gallium Citrate Ga-68 12 Grass Pollen Mixture Motixafortide GUAIACOL Brepocitinib Tosilate Acalabrutinib FLUCLOXACILLIN SODIUM SODIUM DIHYDROGEN PHOSPHATE More therapies…

    Learn about Your Condition

    Dyspnoea Thymic carcinoma Implantation complication Chordoma Plasma cell myeloma Phaeochromocytoma Respiratory distress Corneal dystrophy Type 1 diabetes mellitus Hot flush Rectal cancer Vasoplegia syndrome Myelodysplastic syndrome Haemorrhagic stroke Cutaneous calcification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • Raludotatug Deruxtecan
    • Ifinatamab Deruxtecan
    • Docetaxel
    Germany Greece Hungary Italy Poland Spain

  • Evaluating Different Durations of Antibiotic Treatment for Respiratory Tract Infections and Rhinosinusitis in Adults Receiving Beta-lactam Antibiotics

    Recruiting

    3 1 1 1
    Spain

  • Study of beta blockers in patients with aortic stenosis undergoing transcatheter aortic valve replacement

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic stenosis
    Austria Germany

  • Study of telisotuzumab adizutecan with osimertinib as first treatment for adults with advanced or metastatic EGFR-mutated non-small cell lung cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Belgium Italy Portugal Spain

  • Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Dexamethasone Sodium Phosphate
    Poland Spain

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
Previous Page
1 … 155 156 157 158 159 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!